Stay updated with breaking news from Thomas Marron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Significant tumor necrosis greater than 70% occurred in 3 patients with resectable hepatocellular carcinoma following neoadjuvant treatment with low-dose stereotactic body radiation therapy and cemiplimab-rwlc and adjuvant cemiplimab.
The study shows an allergy route that can activate antitumor immunity for non-small cell lung cancer. | Health
Immune cells in lung cancer are connected to allergic conditions found in eczema and asthma.
First dose-escalation results for REGN5668 , a costimulatory bispecific, in combination with Libtayo® showed encouraging initial activity in patients with recurrent ovarian cancer Additional data...
Researchers have identified an allergy pathway that, when blocked, unleashes anti-tumour immunity in mouse models of non-small cell lung cancer (NSCLC).And in an early parallel study in humans, combining immunotherapy with dupilumab -- an ...